ARVN
Arvinas Inc
Price:  
19.74 
USD
Volume:  
2,483,124.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Arvinas Relative Valuation

-1039.4%
Upside

As of 2024-12-13, the Relative Valuation of Arvinas Inc (ARVN) is (185.43) USD. This relative valuation is based on P/E multiples. With the latest stock price at 19.74 USD, the upside of Arvinas Inc based on Relative Valuation is -1039.4%.

The range of the Relative Valuation is (131.96) - (210.68) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 17.4x - 27.8x 24.0x
Forward P/E multiples 17.4x - 27.8x 24.9x
Fair Price (131.96) - (210.68) (185.43)
Upside -768.5% - -1167.3% -1039.4%
19.74 USD
Stock Price
(185.43) USD
Fair Price

Arvinas Relative Valuation - Historical P/E Data

Date P/E
2024-12-12 -2.60
2024-12-11 -2.97
2024-12-10 -3.24
2024-12-09 -3.31
2024-12-06 -3.42
2024-12-05 -3.26
2024-12-04 -3.35
2024-12-03 -3.19
2024-12-02 -3.39
2024-11-29 -3.52
2024-11-27 -3.43
2024-11-26 -3.23
2024-11-25 -3.32
2024-11-22 -3.41
2024-11-21 -3.31
2024-11-20 -2.99
2024-11-19 -2.85
2024-11-18 -3.06
2024-11-15 -2.96
2024-11-14 -3.29
2024-11-13 -3.34
2024-11-12 -3.47
2024-11-11 -3.70
2024-11-08 -3.58
2024-11-07 -3.66
2024-11-06 -3.69
2024-11-05 -3.55
2024-11-04 -3.53
2024-11-01 -3.55
2024-10-31 -3.48
2024-10-30 -3.65
2024-10-29 -3.63
2024-10-28 -3.58
2024-10-25 -3.42
2024-10-24 -3.55
2024-10-23 -3.50
2024-10-22 -3.50
2024-10-21 -3.40
2024-10-18 -3.57
2024-10-17 -3.57
2024-10-16 -3.67
2024-10-15 -3.42
2024-10-14 -3.38
2024-10-11 -3.45
2024-10-10 -3.30
2024-10-09 -3.30
2024-10-08 -3.40
2024-10-07 -3.33
2024-10-04 -3.29
2024-10-03 -3.23